Compare LINC & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LINC | AORT |
|---|---|---|
| Founded | 1946 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2005 | 1996 |
| Metric | LINC | AORT |
|---|---|---|
| Price | $49.85 | $21.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $45.00 | ★ $49.40 |
| AVG Volume (30 Days) | 564.0K | ★ 878.9K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 100.00 | ★ 165.62 |
| EPS | ★ 0.14 | 0.03 |
| Revenue | $261,853,000.00 | ★ $298,836,000.00 |
| Revenue This Year | $15.16 | $14.20 |
| Revenue Next Year | $9.02 | $11.20 |
| P/E Ratio | ★ $329.64 | $741.72 |
| Revenue Growth | ★ 32.98 | 18.01 |
| 52 Week Low | $17.29 | $19.16 |
| 52 Week High | $53.50 | $48.25 |
| Indicator | LINC | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 61.80 | 24.46 |
| Support Level | $45.85 | $19.16 |
| Resistance Level | $53.50 | $24.70 |
| Average True Range (ATR) | 2.29 | 1.11 |
| MACD | -0.28 | 0.08 |
| Stochastic Oscillator | 52.03 | 0.30 |
Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include: Campus Operations and Transitional. The majority of the revenue is generated from the Campus Operations segment, which includes all campuses that are continuing in operation and contribute to the company's core operations and performance.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.